Journal of Korean Neurosurgical Society

The Korean Neurosurgical Society (대한신경외과학회)
권호 표지
DOI QR코드

DOI QR Code

Antiemetic Prophylaxis with Ramosetron for Postoperative Nausea and Vomiting in Patients Undergoing Microvascular Decompression : A Prospective, Randomized Controlled Trial

  • Koo, Chang-Hoon (Department of Anesthesiology & Pain Medicine, Seoul National University Bundang Hospital) ;
  • Ji, So Young (Department of Neurosurgery, Seoul National University Bundang Hospital) ;
  • Bae, Yu Kyung (Department of Anesthesiology & Pain Medicine, Seoul National University Bundang Hospital) ;
  • Jeon, Young-Tae (Department of Anesthesiology & Pain Medicine, Seoul National University Bundang Hospital) ;
  • Ryu, Jung-Hee (Department of Anesthesiology & Pain Medicine, Seoul National University Bundang Hospital) ;
  • Han, Jung Ho (Department of Neurosurgery, Seoul National University Bundang Hospital)
  • Received : 2021.12.02
  • Accepted : 2022.02.07
  • Published : 2022.11.01
Download PDF
⟨ Previous Next ⟩

Abstract

Objective : This prospective, randomized, double-blinded trial aimed to evaluate the efficacy and safety of prophylactic ramosetron administration against postoperative nausea and vomiting (PONV) in patients undergoing microvascular decompression (MVD). Methods : In this study, 100 patients undergoing MVD were randomly allocated to the control (normal saline, 2 mL) or ramosetron (ramosetron, 0.3 mg) groups at the end of surgery. The incidence and severity of PONV, need for rescue antiemetics, patient satisfaction score, duration of hospital stay, and the occurrence of adverse events were evaluated 48 hours post-surgery. Results : Data obtained from 97 patients were included in the final analysis. The incidence of PONV was significantly lower in the ramosetron group than in the control group throughout the 48-hour postoperative period (29.2% vs. 51.0%, p=0.028). A similar trend was observed with regard to PONV severity (p=0.041). The need for rescue antiemetics, satisfaction score, duration of hospital stays, and the occurrence of adverse events did not significantly differ between the groups. Conclusion : Prophylactic ramosetron administration reduced the incidence and severity of PONV in patients undergoing MVD without causing serious adverse events. Thus, ramosetron use may improve patient recovery following MVD.

Keywords

Acknowledgement

This research was funded by Daiichi Sankyo Korea Co. Ltd.

References

  1. Apfel CC, Laara E, Koivuranta M, Greim CA, Roewer N : A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers. Anesthesiology 91 : 693-700, 1999 https://doi.org/10.1097/00000542-199909000-00022
  2. Chandrakantan A, Glass PS : Multimodal therapies for postoperative nausea and vomiting, and pain. Br J Anaesth 107 : i27-i40, 2011 https://doi.org/10.1093/bja/aer358
  3. Cho YJ, Choi GJ, Ahn EJ, Kang H : Pharmacologic interventions for postoperative nausea and vomiting after thyroidectomy: a systematic review and network meta-analysis. PLoS One 16 : e0243865, 2021 https://doi.org/10.1371/journal.pone.0243865
  4. Choi YS, Shim JK, Yoon DH, Jeon DH, Lee JY, Kwak YL : Effect of ramosetron on patient-controlled analgesia related nausea and vomiting after spine surgery in highly susceptible patients: comparison with ondansetron. Spine (Phila Pa 1976) 33 : E602-E606, 2008 https://doi.org/10.1097/BRS.0b013e31817c6bde
  5. Fabling JM, Gan TJ, El-Moalem HE, Warner DS, Borel CO : A randomized, double-blinded comparison of ondansetron, droperidol, and placebo for prevention of postoperative nausea and vomiting after supratentorial craniotomy. Anesth Analg 91 : 358-361, 2000
  6. Fabling JM, Gan TJ, El-Moalem HE, Warner DS, Borel CO : A randomized, double-blind comparison of ondansetron versus placebo for prevention of nausea and vomiting after infratentorial craniotomy. J Neurosurg Anesthesiol 14 : 102-107, 2002 https://doi.org/10.1097/00008506-200204000-00003
  7. Fabling JM, Gan TJ, Guy J, Borel CO, El-Moalem HE, Warner DS : Postoperative nausea and vomiting. a retrospective analysis in patients undergoing elective craniotomy. J Neurosurg Anesthesiol 9 : 308-312, 1997 https://doi.org/10.1097/00008506-199710000-00003
  8. Gan TJ, Belani KG, Bergese S, Chung F, Diemunsch P, Habib AS, et al. : Fourth consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg 131 : 411-448, 2020 https://doi.org/10.1213/ANE.0000000000004833
  9. Go KO, Hwang K, Han JH : Surgical nuances to reduce and manage cerebrospinal fluid leaks after microvascular decompression. J Clin Med 9 : 902, 2020 https://doi.org/10.3390/jcm9040902
  10. Kang HY, Park SW, Lee S, Jeon JM, Oh ID, Choi JH : Effect of prophylactic palonosetron and sugammadex on postoperative nausea and vomiting in patients undergoing microvascular decompression under propofolmaintained anesthesia: a retrospective observational study. Medicine (Baltimore) 97 : e13237, 2018 https://doi.org/10.1097/MD.0000000000013237
  11. Kim WO, Koo BN, Kim YK, Kil HK : Ramosetron for the prevention of postoperative nausea and vomiting (PONV): a meta-analysis. Korean J Anesthesiol 61 : 405-412, 2011 https://doi.org/10.4097/kjae.2011.61.5.405
  12. Kovac AL : Prevention and treatment of postoperative nausea and vomiting. Drugs 59 : 213-243, 2000 https://doi.org/10.2165/00003495-200059020-00005
  13. Lee HH, Kim HM, Lee JE, Jeon YT, Park S, Hwang K, et al. : The effect of a transdermal scopolamine patch on postoperative nausea and vomiting after retromastoid craniectomy with microvascular decompression: a preliminary single center, double-blind, randomized controlled trial. J Clin Med 9 : 156, 2020 https://doi.org/10.3390/jcm9010156
  14. Lee SY, Lee JY, Park SY, Kim JH, Cho OG, Kim JS, et al. : Prophylactic antiemetic efficacy of granisetron or ramosetron in patients undergoing thyroidectomy. Asian J Surg 25 : 309-314, 2002 https://doi.org/10.1016/S1015-9584(09)60197-4
  15. Madenoglu H, Yildiz K, Dogru K, Kurtsoy A, Guler G, Boyaci A : Randomized, double-blinded comparison of tropisetron and placebo for prevention of postoperative nausea and vomiting after supratentorial craniotomy. J Neurosurg Anesthesiol 15 : 82-86, 2003 https://doi.org/10.1097/00008506-200304000-00003
  16. McLaughlin MR, Jannetta PJ, Clyde BL, Subach BR, Comey CH, Resnick DK : Microvascular decompression of cranial nerves: lessons learned after 4400 operations. J Neurosurg 90 : 1-8, 1999 https://doi.org/10.3171/jns.1999.90.1.0001
  17. Meng L, Quinlan JJ : Assessing risk factors for postoperative nausea and vomiting: a retrospective study in patients undergoing retromastoid craniectomy with microvascular decompression of cranial nerves. J Neurosurg Anesthesiol 18 : 235-239, 2006 https://doi.org/10.1097/00008506-200610000-00003
  18. Neufeld SM, Newburn-Cook CV : The efficacy of 5-HT3 receptor antagonists for the prevention of postoperative nausea and vomiting after craniotomy: a meta-analysis. J Neurosurg Anesthesiol 19 : 10-17, 2007 https://doi.org/10.1097/01.ana.0000211025.41797.fc
  19. Pierre S, Whelan R : Nausea and vomiting after surgery. CEACCP 13 : 28-32, 2013
  20. Ryu JH, Lee JE, Lim YJ, Hong DM, Park HP, Han JI, et al. : A prospective, randomized, double-blind, and multicenter trial of prophylactic effects of ramosetronon postoperative nausea and vomiting (PONV) after craniotomy: comparison with ondansetron. BMC Anesthesiol 14 : 63, 2014 https://doi.org/10.1186/1471-2253-14-63
  21. Sato K, Sai S, Adachi T : Is microvascular decompression surgery a high risk for postoperative nausea and vomiting in patients undergoing craniotomy? J Anesth 27 : 725-730, 2013 https://doi.org/10.1007/s00540-013-1621-9
  22. Shaikh SI, Nagarekha D, Hegade G, Marutheesh M : Postoperative nausea and vomiting: a simple yet complex problem. Anesth Essays Res 10 : 388-396, 2016 https://doi.org/10.4103/0259-1162.179310
  23. Thongrong C, Chullabodhi P, Kasemsiri P, Kitkhuandee A, Plailaharn N, Sabangban L, et al. : Effects of intraoperative dexamethasone and ondansetron on postoperative nausea and vomiting in microvascular decompression surgery: a randomized controlled study. Anesthesiol Res Pract 2018 : 6297362, 2018
  24. Trevisani L, Cifala V, Gilli G, Matarese V, Zelante A, Sartori S : Postanaesthetic discharge scoring system to assess patient recovery and discharge after colonoscopy. World J Gastrointest Endosc 5 : 502-507, 2013 https://doi.org/10.4253/wjge.v5.i10.502
  25. Xu G, Zhao J, Liu Z, Liu G, Liu L, Ren C, et al. : Dexmedetomidine combined with butorphanol or sufentanil for the prevention of postoperative nausea and vomiting in patients undergoing microvascular decompression: a randomized controlled trial. Front Med (Lausanne) 7 : 583031, 2020
  26. Yi MS, Kang H, Kim MK, Choi GJ, Park YH, Baek CW, et al. : Relationship between the incidence and risk factors of postoperative nausea and vomiting in patients with intravenous patient-controlled analgesia. Asian J Surg 41 : 301-306, 2018 https://doi.org/10.1016/j.asjsur.2017.01.005